Semaglutide vs BPC-157
Semaglutide (Grade A, weight loss) and BPC-157 (Grade D, healing & recovery) are used for different goals, so this is less "which is better" and more "which fits your aim."
A Semaglutide
Approved GLP-1 drug with robust human trials for weight loss and diabetes.
D BPC-157
Hugely popular for healing; strong animal data, no controlled human trials yet.
Head to head
| Attribute | Semaglutide | BPC-157 |
|---|---|---|
| Evidence grade | Grade A, approved & proven | Grade D, preclinical only |
| Approval | Approved medicine | Research-only |
| Primary use | Weight loss | Healing & recovery |
| In sport (WADA) | Not prohibited | Banned |
Which should you choose?
If you want the better-evidenced option, it’s Semaglutide, its evidence is approved & proven, versus preclinical only for the other. Stronger evidence means fewer unknowns, which matters most on anything you'd put in your body.
Educational comparison, not medical advice or a recommendation to use either. Grades reflect the strength of human evidence. Speak with a qualified healthcare professional before considering any peptide.